- The dental workforce trends that will dominate 2026
- Federal Medicaid cuts threaten dental care access: See the potential impact by state
- Children’s Mercy raises $150M for mental healthcare
- California awards $291M to expand behavioral health housing, services
- Think bigger – Turning AI from Trends to Long-Term Transformation
- UnityPoint Health hospital names market chief nursing officer
- OhioHealth builds well-being programs to reshape caregiver culture
- Washington hospital staff vote ‘no confidence’ in management company
- U of Mississippi Medical Center restores phone lines after cyberattack
- 13 health system IT leadership moves
- How health systems are repositioning informatics
- Mississippi hospital names COO
- Ex-Amazon Health leader joins Spotify founder’s health tech startup
- Know the True Value of Your Lab When an Offer Is on the Table
- U of California offers 32% wage hike in union talks
- UF Health taps new outpatient senior VP
- UAMS names new director of cardiovascular medicine division
- CMS’ add-on billing code boosts specialist pay: Study
- Lawmakers introduce bill to reverse Medicaid cuts, expand Medicare benefits
- Florida medical center to expand with ASC
- New Jersey woman charged with practicing unlicensed dentistry
- CMS extends hospital-at-home waivers for 5 years: What ASCs need to know
- 100+ organizations call on CMS to revise 2027 MA rates
- The retention breakthrough anesthesia needs
- Oklahoma advances interstate compact bill
- Brown University Health names new chief of cardiac surgery
- UNC Health Appalachian offers psychiatric physician training program
- Former PepperPointe Partnerships COO joins DPO
- The Smilist expands into Virginia
- Physician-led orthopedic ASC opens in Florida
- Colorado Medicaid ABA audit finds $77.8M in improper payments
- Georgia opens 30-bed forensic mental health unit to ease jail backlog
- Pennsylvania county cuts ribbon on $19.8M mental health diversion center
- Outpatient cardiology’s CMS whiplash
- 12 new ASCs in February
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- 15 dentists making headlines
- CMS to suspend enrollment into Elevance’s Medicare Advantage plans
- Report: Most states investing in value-based care with Rural Health Transformation Program
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- 10 providers seeking RCM talent
- PDS Health added de novos across 3 states in February
- Novant posts 4.8% operating margin in 2025
- 'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing
- Cleveland Clinic posts $913M operating income, 5% margin — 7 things to know
- Former Optum CEO Heather Cianfrocco to depart UnitedHealth Group
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Clinician Engagement: The Operating Lever Behind Margin and Throughput
- Your Anesthesia Subsidy: Key Questions Every Hospital C-Suite Must Answer
- Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains
- CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Families Defend Disability Services Amid Medicaid Cuts
- Medicaid Is Paying for More Dental Care. GOP Cuts Threaten To Reverse the Trend.
- Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover
- Ascendis gains more altitude with FDA approval for dwarfism drug Yuviwel
- CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- ICE, ALS, Addiction Medicine, and Robotic Ultrasounds: Journalists Sound Off on All That and More
- 11 behavioral health executive moves to know
- 3 behavioral healthcare M&A deals in 2026
- Anthem Blue Cross of California pushes E/M downcoding policy to April
- Iowa dentist surrenders license
- Temple University gets approval for $3.19M rural dental clinic
- A Canadian Hospital Scoops Up Nurses Who No Longer Feel Safe in Trump’s America
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- State Medicaid budgets to weather $664B reduction through 2034 due to OBBBA: RAND
- Clover Health CEO said company sees opportunity in complex MA environment
- How pharma marketers are capturing the power of podcasts to connect with consumers
- Cigna's Evernorth quietly acquires hospital pharmacy CarepathRx
- Walgreens debuts virtual weight management clinic with access to GLP-1 meds
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Merck to wind down Gardasil production at N.C. plant, lay off 150-plus
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- Patrick Kennedy: Collab with MAHA is essential to address mental health crisis
- Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
- Alignment CEO John Kao offers measured response to proposed 2027 MA rates
- Sanofi, Genentech, Kedrion back star-studded bleeding disorder awareness campaign
- Op-ed: Our patients deserve better safety reporting. AI could be the answer
- After CHMP nod, Moderna CEO applauds EU's 'rigorous scientific review'
- UCB's fast-growing Bimzelx leaps across blockbuster sales threshold as HS momentum builds
- How the Brain Learns to Have Seizures During Sleep
- Blood Test Can Predict Short-Term Survival Among Seniors
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
- Wildfire Smoke Linked To Increase In Violent Assaults
- More Parents Are Refusing A Life-Saving Shot For Their Newborns, Study Finds
- He Needs an Expensive Drug. A Copay Card Helped — Until It Didn’t.
- To Avoid Care Disruptions, Know When the Clock Runs Out on Your Prior Authorization
- As SCOTUS takes on 'skinny label' review, top US lawyer sides with generics maker
- Lake Nona Impact Forum: There can't be longevity without tech
- Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up
- Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Smith+Nephew signs distribution agreement with SI-BONE
- Smith+Nephew signs distribution agreement with SI-BONE
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Quantum Surgical Acquires NeuWave Medical, Inc.
- How Pharma is Expanding its Global Footprint to Advance Clinical Research
- Partnering to Advance Drug Delivery Innovation
- What the Health? From KFF Health News: What About the State of Health?
- Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model
- CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health
- Insurance groups say proposed flat Medicare Advantage rates fail to meet the moment
- Health Gorilla urges court to toss lawsuit filed by Epic, health systems
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Democrat-Led States Sue Trump Administration Over Cuts to Childhood Vaccine Schedule
- CDC Vaccine Advisory Panel To Revisit COVID Shot Safety Next Month
- Frozen Blueberry Recall Issued Across Four States for Listeria
- Boehringer's Hernexeos secures speedy first-line expansion in FDA's 2nd national priority nod
- 'Like talking to a brick wall': Senate hearing takes aim at FDA's rare disease review process
- After delay, CDC vaccine panel sets new dates to discuss long COVID and mRNA shot safety
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Cientos de enfermeros estadounidenses dejan atrás el Estados Unidos de Trump y eligen trabajar en Canadá
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
- Could Drone-Delivered Defibrillators Save Lives?
- Inflammation Linked To Brain Damage, Memory Problems Among Football Players
- Early Birds, Active Folks Less Likely To Develop ALS
- Disasters Can Affect Mental Health A Decade Later, Review Finds
- AI Chatbots Can Contribute To Worsening Mental Illness, Study Finds
- Newborns Exposed to More ‘Forever Chemicals’ Than Once Thought
- Study Highlights Unique Parenting Struggles of Younger Patients With Heart Disease
- Altman-backed startup Verifiable rolls out AI agent to automate credentialing
- ‘You Aren’t Trapped’: Hundreds of US Nurses Choose Canada Over Trump’s America
- ‘Kind of Morbid’: Health Premiums Threaten Their Nest Egg. A Terminal Diagnosis May Spare It.
The once and future President Trump has nominated Dr. Martin Adel Makary to head the Food and Drug Administration. Stanley Goldfarb, an emeritus professor of medicine at the University of Pennsylvania, has just posted a review of Dr. Makary's latest book: Blind Spots:When Medicine Gets It Wrong, and What It Means for Our Health. The review gives you some insight into Dr. Makary's thoughts on health care in America:
https://freebeacon.com/culture/in-search-of-a-second-opinion/
In Search of a Second Opinion
REVIEW: ‘Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health’ by Marty Makary
By Stanley Goldfarb - November 24, 2024When patients turn to professional societies like the AMA or the American College of Physicians or the American Association of Pediatrics for vital health information, one might expect that the information is based on publications in prestigious medical journals of carefully designed and meticulously interpreted studies. Dr. Marty Makary, in his book Blind Spots, shows how wrong these assumptions can be.
Makary is a frequent commentator on health-related topics. He is a surgeon and surgical oncologist at Johns Hopkins Hospital. Blind Spots consists of several examples where the medical establishment has perpetuated a myth often based on a single academic’s opinion that became ingrained in the culture as "truth" despite the flimsiest of evidence. Using examples like avoiding exposure to peanuts in infants, producing an epidemic of peanut allergy, or denying the benefits of hormone replacement therapy in perimenopausal women, resulting in premature deaths and suboptimal health outcomes, Makary proves his case against groupthink in medicine. He goes on to rail against the overuse of antibiotics because of their potential for altering the microbial composition in the GI tract. Recent research shows that this effect of antibiotics may contribute to serious complications, including risks for cancer and cardiovascular disease.
Another section recounts the saga of the treatment of ulcers of the upper GI tract. Ulcer disease was treated as a neuropsychiatric disorder that required behavioral modification and buffering stomach acid to prevent recurrences. The evidence that a particular bacterium caused stomach ulcers was known for several years, but the medical establishment resisted this insight simply because it flew against conventional wisdom. Eventually, Dr. Barry Marshall won the Nobel Prize in medicine for the discovery. He had to induce his own ulcer disease by ingesting the bacteria that he identified to finally convince the skeptics.
Makary also visits the controversy about so-called gender-affirming care for children. This treatment involves drugs that prevent children with confusion about their sexuality from experiencing a normal puberty, administers sex characteristic-altering hormones, and even life-altering surgical procedures like mastectomies. He quotes some of the most thoughtful critics of these procedures, such as Lisa Littman, who first identified the phenomenon of the rapid onset of gender dysphoria when teenage girls first encounter the earliest phases of puberty. Despite overwhelming evidence that she was correct in her idea that these children had a temporary form of juvenile angst, she was effectively "canceled" because the concept undermined the theory of an underlying biological basis for the psychological disorder.
Gender-affirming care is yet another idea that falls into the category of dangerous treatments accepted by the medical establishment despite ongoing proof that it harms many children. Sadly, almost every major American medical society supports gender-affirming care for these troubled children, while several European nations have examined their own experience with this therapy and the published medical evidence with an open mind and now severely restrict its implementation.
Readers will find this book interesting if they have not had much of a background in biomedical science. It is clear, concise, and well-documented. They may ask a few more questions at their yearly checkup, and that is a good thing.
Why do these wrongheaded approaches to medical care exist, and what can be done to prevent their perpetuation? Makary describes the phenomenon of maintaining a closed mind in the face of contravening data but never quite gets to the originating cause of this attitude in the medical establishment. He does make a strong case for the benefit of classical liberal principles, such as freedom of speech and willingness to confront hierarchies as antidotes. But at a time when conformity and groupthink seem to have taken hold of the most recent generations of physicians, Makary nonetheless praises the current young generation as including vigorous disruptors who will challenge the medical status quo. But has he watched the cult-like recitations of new medical students at their white coat ceremonies about land acknowledgments to indigenous people and obeisance to the oppressor/oppressed paradigm of "systemic racism"? They don’t seem likely to challenge anything.
The unwillingness to have an open mind when examining controversial topics or confronting new information suggests a deeper problem. The problem is, in large part, the culture of medical education. More and more, physicians are taught and regurgitate the "facts." Medicine has increasingly focused on doing rather than knowing. The monetary rewards are skewed toward performing procedures and tests. Understanding basic disease mechanisms or evaluating the quality of medical studies are less valued. This is not a new problem, and Makary cites examples of physicians ignoring best practices or new knowledge in favor of traditional approaches going back centuries. It is easy to understand how this attitude predominated in the era when medical science was primitive, and all that existed was opinion. But modern medical science allows physicians to approach clinical problems with a deep understanding of the mechanisms of disease and underlying biomedical science. Despite this, the failure to improve the closed-mindedness is ongoing. The problem has become more acute given the recent trend in training medical students to be social justice warriors rather than rigorous clinical scientists.
Medical students now learn almost exclusively through taking practice exams and studying the answers to the multiple-choice questions that make up the exams. It is virtually unheard of for students to be assigned textbooks or even specific articles in the medical literature and then asked to interpret the information. They chafe when presented with basic science information if its clinical relevance is not immediately obvious. Yet such knowledge is crucial to good medicine.
To develop independent thinking among physicians, the medical curriculum should develop critical thinking skills about biomedical topics, and students recruited to become physicians should be those who embrace such an approach. Instead, students are increasingly chosen based on their agreement with theories of "systemic racism" and "social determinants of health" rather than their potential to become clinical scientists.
Makary believes that among the current crop of trainees are those who will disrupt the modes of thinking that produce the wrongheaded outcomes he describes. I fear he is wrong in his prescription. I think a more active intervention is needed. Undergraduate and graduate medical education need a reform agenda. Deep learning on experimental design, data interpretation, critical reading of the medical literature, and understanding the philosophy of science should replace the many hours currently spent trying to turn young physicians into social workers.
Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health
by Marty Makary
Bloomsbury Publishing, 288 pp., $28.99
Stanley Goldfarb is an emeritus professor of medicine at the University of Pennsylvania and father of Washington Free Beacon chairman Michael Goldfarb.
In short - med students need training in how to think, instead of what to think.
I couldn't agree more! Cookie-cutter medicine is letting patients everywhere fall through the cracks.
Another fascinating take on Dr. Makary comes from his previous employer and my frequent source in this Forum for Healthcare Headlines.
https://www.medpagetoday.com/washington-watch/fdageneral/113078
Trump's FDA Pick Is MedPage Today's Former Top Editor
— Marty Makary has made a name for himself challenging the medical establishment
President-elect Donald Trump has chosen Marty Makary, MD, MPH, to run the FDA.
Makary served as the editor-in-chief of MedPage Today from January 2020 through the end of 2021.
"FDA has lost the trust of Americans, and has lost sight of its primary goal as a regulator. The Agency needs Dr. Marty Makary, a Highly Respected Johns Hopkins Surgical Oncologist and Health Policy Expert, to course-correct and refocus the Agency," Trump said on Friday, in announcing the nomination on Truth Social.
"He will work under the leadership of Robert F. Kennedy Jr. to, among other things, properly evaluate harmful chemicals poisoning our Nation's food supply and drugs and biologics being given to our Nation's youth, so that we can finally address the Childhood Chronic Disease Epidemic," Trump added.
Trump also announced the nominations of Dave Weldon, MD, for CDC Director and Janette Nesheiwat, MD, for U.S. Surgeon General.
Makary has written three books on medicine and healthcare: Blind Spots, The Price We Pay, and Unaccountable, the last of which was turned into a TV series called "The Resident." A theme of all three books is challenging the status quo in medicine, questioning the evidence base for certain treatments and established clinical practices. Among his top issues, Makary has taken on the high costs of healthcare and medicine's penchant for overtreatment. He also authored Mama Maggie, a book about a woman who aids the poor people of Egypt's slums.
Early in the COVID-19 pandemic, Makary espoused some views that were in opposition to mainstream medicine, including championing the power of natural immunity, challenging vaccine mandates, and questioning the need for COVID vaccines in children. Makary famously predicted in February 2021 that the U.S. would have "herd immunity by April" 2021.
In 2023, Makary testified before Congress that a lab leak origin of SARS-CoV-2 from the Wuhan Institute of Virology in China was a "no-brainer."
More recently, he has reverted to speaking out against the core business-of-healthcare issues that initially sparked his rise to fame, including how hospitals that make profits should pay taxes, and exposing how certain Medicare policies enable hospital and health system monopolies.
Makary completed his surgical residency at Georgetown University Hospital in Washington, D.C., after attending medical school at Thomas Jefferson University in Philadelphia. He received his Master of Public Health degree from Harvard University. In 2018 he was elected to the National Academy of Medicine.
At FDA, Makary would be in charge of the agency's annual budget of $7 billion, and he would report to Kennedy, Trump's pick for HHS secretary, if confirmed by the Senate.
Late last month, Kennedy lashed out at the FDA in a post on X: "FDA's war on public health is about to end. This includes its aggressive suppression of psychedelics, peptides, stem cells, raw milk, hyperbaric therapies, chelating compounds, ivermectin, hydroxychloroquine, vitamins, clean foods, sunshine, exercise, nutraceuticals, and anything else that advances human health and can't be patented by Pharma. If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags."
Outgoing FDA Commissioner Robert Califf, MD, has fought against medical misinformation, and pushed for improvements in food safety and inspections. He recently said that under a Trump administration, FDA's ability to hire and retain skilled employees could be in jeopardy, given Kennedy's hostility to civil servants.
Dr. Martin Adel Makary is now the Commissioner of the Food and Drug Administration:
https://thehill.com/homenews/administration/5214293-senate-confirms-marty-makary-fda/
Senate confirms Marty Makary to lead FDA
By Nathaniel Weixel - March 25, 2025The Senate on Tuesday night confirmed Marty Makary to be the Food and Drug Administration commissioner.
Makary was easily confirmed by a 56-44 vote, picking up three Democrats.
Democratic Sens. Dick Durbin (Ill.) Maggie Hassan (N.H.) and Jeanne Shaheen (N.H.) voted with all Republicans to confirm Makary.
A Johns Hopkins surgeon, Makary will take over an agency hammered by workforce cuts imposed by Elon Musk’s Department of Government Efficiency.
He will also have to navigate politically tricky decisions on access to the abortion medication mifepristone, as well as about vaccine policy under Health and Human Services Secretary Robert F. Kennedy Jr, a prominent vaccine skeptic.
Democrats hammered Makary during his confirmation hearing on recent moves by the Trump administration to cut FDA staff and pressed him on plans to exercise his authority over mifepristone.
GOP senators urged him to curb access, while Democrats pressed him to keep the current policies in place.
Makary tread carefully in his responses, saying he had no preconceived notions about the drugs and would “take a solid, hard look at the data” about mifepristone’s safety.
Makary was a critic of federal COVID-19 mitigation policies and frequently appeared on Fox News during the pandemic.
Makary during his hearing largely said he supported the benefits of vaccines, even as he was being pressed about the recent cancellation of agency advisory panels.
“Vaccines save lives, and I do believe that any child who dies of a vaccine-preventable illness is a tragedy in the modern era,” he said.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















